(ORR) and 92% disease control rate (DCR) observed with MICVO as monotherapy in 2L+ R/M HNSCC at 5.4 mg/kg 71% confirmed ORR ...

AstraZeneca’s exclusive global licensing deal for Jacobio’s pan-KRAS inhibitor JAB-23E73 underscores a renewed industry push of one of oncology’s most elusive targets. AstraZeneca has announced it has ...

This study provides important evidence that negative affect is associated with slower cognitive processing in daily life, with findings replicated across three independent samples and supported by ...

An agentic AI-based approach to end-to-end bug resolution using both error logs and waveforms.

This study found that certain characteristics in linked electronic health record data across episodes of care can help identify patients with Alzheimer disease and related dementias at high risk of 30 ...

Kalaris Therapeutics offers differentiated approach to neovascular AMD with its lead candidate TH103. Click here to read my ...

Pyxis Oncology (PYXS) announced preliminary data from its ongoing Phase 1 clinical studies evaluating micvotabart pelidotin, a first-in-concept ...

Despite ongoing tariff uncertainty and sluggish growth, Mexico has delivered an extraordinary year; the iShares MSCI Mexico ETF ( EWW) has a YTD performance of close to 50%, outperforming both the ...

Association of paleopalynological data from the Nanxiong Basin, south China, and late Paleocene niche expansion in endemic Asian fossil mammals.

Significant treatment options are changing the management of CLL, according to research presented at the ASH Annual Meeting 2025.

Background The likelihood of HIV acquisition is increased following forced vaginal sex. This relates in part to ...

Here's a look back at Week 15's action and fantasy advice for the week ahead: WEEK 15 RECAP Falcons 29, Buccaneers 28: Kyle ...